Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cannabis Stocks Profiles

View company profiles of publicly traded cannabis, marijuana, and 420 friendly Stocks.
Mon, May 19th, 2025

Cannabis/marijuana stocks represent new investment opportunities as public companies provide products and services for medical and recreational use. Worldwide spending on legal cannabis reached $21.3 billion in 2020 and some analysts expect that that number could surpass $50 billion if nationwide legalization were to occur. Given this potential opportunity, investors are now speculating which marijuana-related stocks could become the dominant players in the future. Barchart’s cannabis stocks list is a great starting point that will allow you to find investment opportunities and compare stocks involved in the growing cannabis industry.

Incannex Healthcare Inc ADR (IXHL)

Full Profile

Incannex Healthcare Limited is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs. Incannex Healthcare Limited is based in MELBOURNE, Australia.

52-Week Low
52-Week High
0.0800
3.5500

Overview:

Market Capitalization, $K 4,644
Shares Outstanding, K 17,860
Last Quarter Sales 10 K
Last Quarter Net Income -5,890 K
% Insider Shareholders 26.53%
% Institutional Shareholders 0.43%

Canopy Growth Corp (CGC)

Full Profile

Canopy Growth Corporation is a cannabis company. It offers dry cannabis and oil products primarily under the Tweed brand. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

52-Week Low
52-Week High
0.7700
11.6500

Overview:

Market Capitalization, $K 305,216
Shares Outstanding, K 183,865
Last Quarter Sales 53,390 K
Last Quarter Net Income -87,060 K
% Insider Shareholders 1.30%
% Institutional Shareholders 3.33%

Tilray Brands Inc (TLRY)

Full Profile

Tilray Brands Inc. is a cannabis-lifestyle and consumer packaged goods company. It operates principally in Canada, the United States, Europe, Australia and Latin America. Tilray Brands Inc., formerly known as Tilray Inc., is based in NEW YORK.

52-Week Low
52-Week High
0.4138
2.1500

Overview:

Market Capitalization, $K 498,216
Shares Outstanding, K 1,006,496
Last Quarter Sales 185,780 K
Last Quarter Net Income -789,440 K
% Insider Shareholders 0.87%
% Institutional Shareholders 9.35%

Scotts Miracle-Gro Company (SMG)

Full Profile

The Scotts Miracle-Gro Company is a leading producer and marketer of branded garden and consumer lawn products. The company makes, markets and sells garden and lawn products in various categories. Its products are marketed under some of the most recognized brands like Scotts & Turf Builder lawn and grass seed products, LiquaFeed and Osmocote gardening and landscape products, Miracle-Gro plant fertilizers, EverGreen lawn fertilizers, Weedol and Pathclear herbicides and Levington gardening and landscape products. Its has three reportable business segments: U.S. Consumer, Hawthorne and Other. U.S. Consumer division consists of consumer garden and lawn business. The lawn care products also include lawn-related pest, weed and disease control products. Hawthorne segment consists of urban, indoor and hydroponic gardening business. Other division consists of consumer lawn and garden business in regions other than the U.S. and the products are sold to commercial nurseries, greenhouses and other professional customers.

52-Week Low
52-Week High
45.61
93.90

Overview:

Market Capitalization, $K 3,604,302
Shares Outstanding, K 57,715
Last Quarter Sales 1,421 M
Last Quarter Net Income 217,500 K
% Insider Shareholders 25.37%
% Institutional Shareholders 74.07%

Organigram Global Inc (OGI)

Full Profile

Organigram Global Inc. is focused on producing cannabis for adult recreational consumers. Organigram Global Inc., formerly known as OrganiGram Holdings Inc, is based in TORONTO.

52-Week Low
52-Week High
0.8500
2.1100

Overview:

Market Capitalization, $K 182,017
Shares Outstanding, K 133,836
Last Quarter Sales 30,520 K
Last Quarter Net Income -16,400 K
% Insider Shareholders 0.09%
% Institutional Shareholders 34.63%

Corbus Pharmaceuticals Hldgs Inc (CRBP)

Full Profile

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.

52-Week Low
52-Week High
4.64
61.90

Overview:

Market Capitalization, $K 89,820
Shares Outstanding, K 12,237
Last Quarter Sales 0 K
Last Quarter Net Income -16,980 K
% Insider Shareholders 3.60%
% Institutional Shareholders 64.64%

Jazz Pharma Plc (JAZZ)

Full Profile

Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus in the areas of neuroscience & oncology. It derives the majority of its revenues from its sleep disorder drugs' Xywav & Xyrem. Both drugs are approved for treating cataplexy & excessive daytime sleepiness in narcolepsy patients. Other drugs in the company's neuroscience portfolio include' Sunosi, Epidiolex & Sativex. Epidiolex is approved for treating seizures associated with two rare & severe forms of epilepsy' Lennox-Gastaut syndrome & Dravet syndrome. Sativex is approved in the U.K. & Canada as a treatment for symptom improvement in adult patients with moderate-to-severe spasticity due to multiple sclerosis. Jazz's oncology portfolio includes two drugs' Defitelio for the treatment hepatic veno-occlusive disease with renal or pulmonary dysfunction following hematopoietic stem cell transplantation & Vyxeos for the treatment of adults with two types of acute myeloid leukemia. It received approval for two new drugs' Zepzelca & Rylaze'.

52-Week Low
52-Week High
95.49
148.06

Overview:

Market Capitalization, $K 6,716,764
Shares Outstanding, K 61,633
Last Quarter Sales 897,840 K
Last Quarter Net Income -92,540 K
% Insider Shareholders 4.20%
% Institutional Shareholders 89.14%

Growgeneration Corp (GRWG)

Full Profile

GrowGeneration Corp. owns and operates specialty retail hydroponic and organic gardening stores. The company carries and sells product which includes organic nutrients and soils, advanced lighting technology and state of the art hydroponic equipment to be used indoors and outdoors by commercial and home growers. It operates primarily in Colorado, California, Las Vegas, Rhode Island and Washington. GrowGeneration Corp. is headquartered in Pueblo, Colorado.

52-Week Low
52-Week High
0.8211
2.9300

Overview:

Market Capitalization, $K 67,825
Shares Outstanding, K 59,496
Last Quarter Sales 35,700 K
Last Quarter Net Income -9,380 K
% Insider Shareholders 7.62%
% Institutional Shareholders 36.02%

Cronos Group Inc (CRON)

Full Profile

Cronos Group, Inc. engages in the investment in firms which are licensed to produce and sell medical marijuana. Its portfolio includes In The Zone, Peace Naturals, Whistler Medical Marijuana Co., ABcann, Hydropothecary, Vert Medical and Evergreen Medicinal Supply. Cronos Group Inc., formerly known as PharmaCan Capital Corp., is headquartered in Toronto, Canada.

52-Week Low
52-Week High
1.60
3.12

Overview:

Market Capitalization, $K 824,771
Shares Outstanding, K 385,407
Last Quarter Sales 32,260 K
Last Quarter Net Income 6,120 K
% Insider Shareholders 7.30%
% Institutional Shareholders 8.71%

Sndl Inc (SNDL)

Full Profile

SNDL INC. is a private sector cannabis and liquor retailer principally in Canada. The company's operated and reported segment includes Cannabis Production and Cultivation, Cannabis Retail, Liquor Retail and Investments. Its retail banners include Spiritleaf, Value Buds, Wine and Beyond, Liquor Depot and Ace Liquor. SNDL INC., formerly known as Sundial Growers Inc., is based in CALGARY, AB.

52-Week Low
52-Week High
1.2400
2.7400

Overview:

Market Capitalization, $K 354,748
Shares Outstanding, K 262,776
Last Quarter Sales 142,700 K
Last Quarter Net Income -10,240 K
% Insider Shareholders N/A
% Institutional Shareholders 0.00%

Constellation Brands Inc (STZ)

Full Profile

Constellation Brands Inc. produces and markets beer, wine and spirits. It is the third-largest beer company and a leading, high-end wine company in the United States. It has a strong portfolio of high-quality brands, including Corona, Modelo Especial, Robert Mondavi, Kim Crawford, Meiomi and SVEDKA Vodka. The company conducts its operations in the United States, Mexico, Italy and New Zealand.Furthermore, the company supplies its products to various customers, including wholesale distributors, retailers and through on-premise outlets. As part of its total beverage alcohol strategy, the company extended presence in an adjacent category through its investment in Canopy Growth Company, a diversified cannabis company. The company reports in four operating segments: (1) Beer, (2) Wine and Spirits, and (3) Corporate Operations and Other, and (4) Canopy.

52-Week Low
52-Week High
160.46
265.70

Overview:

Market Capitalization, $K 34,824,272
Shares Outstanding, K 178,020
Last Quarter Sales 2,164 M
Last Quarter Net Income -375,300 K
% Insider Shareholders 12.19%
% Institutional Shareholders 77.34%

Trulieve Cannabis Corp (TCNNF)

Full Profile

N/A

52-Week Low
52-Week High
3.0200
13.7800

Overview:

Market Capitalization, $K N/A
Shares Outstanding, K N/A
Last Quarter Sales N/A
Last Quarter Net Income N/A
% Insider Shareholders N/A
% Institutional Shareholders N/A

Green Thumb Industries Inc (GTBIF)

Full Profile

Green Thumb Industries Inc. is a cannabis consumer packaged goods company and owner of RYTHM, Dogwalkers and branded cannabis products. Green Thumb Industries Inc. is based in CHICAGO.

52-Week Low
52-Week High
4.6300
13.4500

Overview:

Market Capitalization, $K 1,182,083
Shares Outstanding, K 211,710
Last Quarter Sales 279,540 K
Last Quarter Net Income 8,310 K
% Insider Shareholders 10.40%
% Institutional Shareholders 0.09%

Abbvie Inc (ABBV)

Full Profile

AbbVie has become one of the top-most pharma companies after it acquired Allergan. The deal has transformed AbbVie's portfolio by lowering its dependence on Humira, its flagship product. AbbVie has one of the most popular cancer drugs in its portfolio, Imbruvica and its newest immunology drugs Skyrizi and Rinvoq position it well for long-term growth. AbbVie came into existence after Abbott Laboratories divested its pharmaceutical division. AbbVie enjoys leadership positions in key therapeutic areas including immunology, hematologic oncology, neuroscience, aesthetics, eye care and womens' health. Humira is approved for several autoimmune diseases like rheumatoid arthritis, active psoriatic arthritis, active ankylosing spondylitis, Crohn's disease and others. Imbruvica became part of the company's portfolio following the Pharmacyclics acquisition. Other key drugs include Venclexta, Botox Cosmetic, Botox Therapeutics, Vraylar, Skyrizi and Rinvoq.

52-Week Low
52-Week High
153.58
218.66

Overview:

Market Capitalization, $K 325,053,472
Shares Outstanding, K 1,766,403
Last Quarter Sales 13,343 M
Last Quarter Net Income 1,286 M
% Insider Shareholders 0.25%
% Institutional Shareholders 70.23%

Curaleaf Holdings Inc (CURLF)

Full Profile

Curaleaf Holdings Inc. operates as a holding company, through its subsidiaries, engages in the production and distribution of cannabis products. Curaleaf Holdings serves dispensary and cultivation sites principally in North America. Curaleaf Holdings Inc. is based in Wakefield, Massachusetts.

52-Week Low
52-Week High
0.6750
5.8150

Overview:

Market Capitalization, $K 552,497
Shares Outstanding, K 663,182
Last Quarter Sales 310,010 K
Last Quarter Net Income -61,060 K
% Insider Shareholders N/A
% Institutional Shareholders 0.03%

Altria Group (MO)

Full Profile

Altria has a leading portfolio of tobacco products for U.S. tobacco consumers age 21 . Altria's wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products. In combustibles, Altria owns Philip Morris USA Inc. (PM USA), the most profitable U.S. cigarette manufacturer, and John Middleton Co. (Middleton), a leading U.S. cigar manufacturer. Altria's smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), the leading global moist smokeless tobacco (MST) manufacturer, and Helix Innovations LLC (Helix), a rapidly growing manufacturer of oral nicotine pouches. Altria also owns equity investments in Anheuser-Busch InBev SA/NV (ABI), the world's largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company.

52-Week Low
52-Week High
43.83
61.26

Overview:

Market Capitalization, $K 99,197,376
Shares Outstanding, K 1,684,452
Last Quarter Sales 5,259 M
Last Quarter Net Income 1,077 M
% Insider Shareholders 0.08%
% Institutional Shareholders 57.41%

Wm Technology Inc (MAPS)

Full Profile

WM TECHNOLOGY is a technology and software infrastructure provider to the cannabis industry. WM TECHNOLOGY, formerly known as Silver Spike Acquisition Corp., is based in IRVINE, Calif.

52-Week Low
52-Week High
0.7000
1.6500

Overview:

Market Capitalization, $K 166,696
Shares Outstanding, K 154,348
Last Quarter Sales 44,610 K
Last Quarter Net Income 1,650 K
% Insider Shareholders 23.64%
% Institutional Shareholders 22.02%

Verano Hldgs Corp (VRNOF)

Full Profile

Verano Holdings Corp. is a multi-state cannabis company. It produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano(TM), Avexia(TM), Encore(TM) and M'V(TM). Verano Holdings Corp. is based in CHICAGO.

52-Week Low
52-Week High
0.4100
5.5100

Overview:

Market Capitalization, $K 235,364
Shares Outstanding, K 358,950
Last Quarter Sales 209,810 K
Last Quarter Net Income -11,520 K
% Insider Shareholders 10.40%
% Institutional Shareholders 8.98%

Cresco Labs Inc (CRLBF)

Full Profile

Cresco Labs Inc. is an integrated multistate cannabis operators principally in the United States. Its brands are designed to meet the needs of all consumer segments and comprised of brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Cresco Labs Inc. is based in CHICAGO.

52-Week Low
52-Week High
0.5200
2.3000

Overview:

Market Capitalization, $K 334,628
Shares Outstanding, K 491,017
Last Quarter Sales 175,910 K
Last Quarter Net Income -4,370 K
% Insider Shareholders N/A
% Institutional Shareholders 0.05%

Ayr Wellness Inc (AYRWF)

Full Profile

Ayr Wellness Inc. is a vertically integrated, multi-state cannabis operator, focused on delivering cannabis products and customer experience. Ayr Wellness Inc., formerly known as AYR WIRELESS, is based in MIAMI.

52-Week Low
52-Week High
0.1160
3.0384

Overview:

Market Capitalization, $K 27,884
Shares Outstanding, K 116,185
Last Quarter Sales 113,960 K
Last Quarter Net Income -161,590 K
% Insider Shareholders 8.10%
% Institutional Shareholders 0.91%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar